These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31078306)

  • 1. Update on Recurrent Respiratory Papillomatosis.
    Derkay CS; Bluher AE
    Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
    Yiu Y; Fayson S; Smith H; Matrka L
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent respiratory papillomatosis: update 2018.
    Derkay CS; Bluher AE
    Curr Opin Otolaryngol Head Neck Surg; 2018 Dec; 26(6):421-425. PubMed ID: 30300210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients.
    Tam S; Wu CF; Peng HL; Dahlstrom KR; Sturgis EM; Lairson DR
    Laryngoscope; 2020 May; 130(5):1186-1194. PubMed ID: 31194270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].
    Pan XF; Wang J; Xiao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):189-192. PubMed ID: 30808153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perspectives on recurrent respiratory papillomatosis and human papillomavirus].
    Trolle S; Lynggaard CD; Gregersen KG; Baandrup L; Grønhøj C; Buchwald CV
    Ugeskr Laeger; 2019 Oct; 181(41):. PubMed ID: 31610833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Watson M; Lowy DR; Markowitz LE
    Vaccine; 2012 Sep; 30(42):6016-9. PubMed ID: 22867718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV and recurrent respiratory papillomatosis: a modern virus and a serious disease with controversial management.
    Nikolopoulos TP
    Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1917-8. PubMed ID: 24139588
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent respiratory papillomatosis: A possible role for the HPV vaccine?
    Lively JM; Shah RK
    JAAPA; 2013 May; 26(5):48, 51-3. PubMed ID: 23682456
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.
    Sullivan C; Curtis S; Mouzakes J
    Int J Pediatr Otorhinolaryngol; 2017 Feb; 93():103-106. PubMed ID: 28109479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward prevention or cure for recurrent respiratory papillomatosis.
    Hughes OR
    Laryngoscope; 2012 Dec; 122 Suppl 4():S63-4. PubMed ID: 23254606
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
    Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
    JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in Korea.
    Oh JK; Choi HY; Han M; Jung YS; Lee SJ; Ki M
    Epidemiol Health; 2021; 43():e2021019. PubMed ID: 33906285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
    Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
    Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates.
    Novakovic D; Cheng AT; Baguley K; Walker P; Harrison H; Soma M; Malloy M; Brotherton JM
    Laryngoscope; 2016 Dec; 126(12):2827-2832. PubMed ID: 27074766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
    Nyirjesy S; Osmundson P; Matrka L
    J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
    Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
    JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
    Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
    Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
    Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
    J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.